Search

Your search keyword '"Catalano, Paul J."' showing total 34 results
Start Over Author "Catalano, Paul J." Publisher american association for cancer research (aacr)
34 results on '"Catalano, Paul J."'

1. Figure S6 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

2. Figure S2 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

3. Figure S3 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

4. Figure S4 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

5. Figure S3 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

6. Figure S5 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

7. Data from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

8. Supplementary Methods 1 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

9. Figure S4 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

10. Data from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

11. Figure S5 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

12. Supplementary Methods 1 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

13. Figure S1 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

14. Figure S6 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

15. Figure S1 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

16. Supplementary Tables 1-6 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

17. Supplementary Tables 1-6 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

18. Figure S2 from PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., primary, Matar, Sayed, primary, El Ahmar, Nourhan, primary, West, Destiny J., primary, Walton, Emily, primary, Bagheri, Aseman Sheshdeh, primary, Savla, Varunika, primary, Nabil Laimon, Yasmin, primary, Gupta, Saurabh, primary, Vemula, Sai Vikram, primary, Braun, David A., primary, Burke, Kelly P., primary, Catalano, Paul J., primary, Freeman, Gordon J., primary, Motzer, Robert J., primary, Atkins, Michael B., primary, McDermott, David F., primary, Sharpe, Arlene H., primary, Choueiri, Toni K., primary, and Signoretti, Sabina, primary

Published
2024
Full Text
View/download PDF

19. PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Author

Denize, Thomas, primary, Jegede, Opeyemi A., additional, Matar, Sayed, additional, El Ahmar, Nourhan, additional, West, Destiny J., additional, Walton, Emily, additional, Bagheri, Aseman Sheshdeh, additional, Savla, Varunika, additional, Nabil Laimon, Yasmin, additional, Gupta, Saurabh, additional, Vemula, Sai Vikram, additional, Braun, David A., additional, Burke, Kelly P., additional, Catalano, Paul J., additional, Freeman, Gordon J., additional, Motzer, Robert J., additional, Atkins, Michael B., additional, McDermott, David F., additional, Sharpe, Arlene H., additional, Choueiri, Toni K., additional, and Signoretti, Sabina, additional

Published
2023
Full Text
View/download PDF

20. Data from KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1

Author

Bhatt, Rupal S., primary, Berjis, Abdulla, primary, Konge, Julie C., primary, Mahoney, Kathleen M., primary, Klee, Alyssa N., primary, Freeman, Samuel S., primary, Chen, Chun-Hau, primary, Jegede, Opeyemi A., primary, Catalano, Paul J., primary, Pignon, Jean-Christophe, primary, Sticco-Ivins, Maura, primary, Zhu, Baogong, primary, Hua, Ping, primary, Soden, Jo, primary, Zhu, Jie, primary, McDermott, David F., primary, Arulanandam, Antonio R., primary, Signoretti, Sabina, primary, and Freeman, Gordon J., primary

Published
2023
Full Text
View/download PDF

21. Data from KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1

Author

Bhatt, Rupal S., primary, Berjis, Abdulla, primary, Konge, Julie C., primary, Mahoney, Kathleen M., primary, Klee, Alyssa N., primary, Freeman, Samuel S., primary, Chen, Chun-Hau, primary, Jegede, Opeyemi A., primary, Catalano, Paul J., primary, Pignon, Jean-Christophe, primary, Sticco-Ivins, Maura, primary, Zhu, Baogong, primary, Hua, Ping, primary, Soden, Jo, primary, Zhu, Jie, primary, McDermott, David F., primary, Arulanandam, Antonio R., primary, Signoretti, Sabina, primary, and Freeman, Gordon J., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Figures and Tables from KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1

Author

Bhatt, Rupal S., primary, Berjis, Abdulla, primary, Konge, Julie C., primary, Mahoney, Kathleen M., primary, Klee, Alyssa N., primary, Freeman, Samuel S., primary, Chen, Chun-Hau, primary, Jegede, Opeyemi A., primary, Catalano, Paul J., primary, Pignon, Jean-Christophe, primary, Sticco-Ivins, Maura, primary, Zhu, Baogong, primary, Hua, Ping, primary, Soden, Jo, primary, Zhu, Jie, primary, McDermott, David F., primary, Arulanandam, Antonio R., primary, Signoretti, Sabina, primary, and Freeman, Gordon J., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figures and Tables from KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1

Author

Bhatt, Rupal S., primary, Berjis, Abdulla, primary, Konge, Julie C., primary, Mahoney, Kathleen M., primary, Klee, Alyssa N., primary, Freeman, Samuel S., primary, Chen, Chun-Hau, primary, Jegede, Opeyemi A., primary, Catalano, Paul J., primary, Pignon, Jean-Christophe, primary, Sticco-Ivins, Maura, primary, Zhu, Baogong, primary, Hua, Ping, primary, Soden, Jo, primary, Zhu, Jie, primary, McDermott, David F., primary, Arulanandam, Antonio R., primary, Signoretti, Sabina, primary, and Freeman, Gordon J., primary

Published
2023
Full Text
View/download PDF

28. Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma

Author

Ficial, Miriam, primary, Jegede, Opeyemi A., additional, Sant'Angelo, Miriam, additional, Hou, Yue, additional, Flaifel, Abdallah, additional, Pignon, Jean-Christophe, additional, Braun, David A., additional, Wind-Rotolo, Megan, additional, Sticco-Ivins, Maura A., additional, Catalano, Paul J., additional, Freeman, Gordon J., additional, Sharpe, Arlene H., additional, Hodi, F. Stephen, additional, Motzer, Robert J., additional, Wu, Catherine J., additional, Atkins, Michael B., additional, McDermott, David F., additional, Shukla, Sachet A., additional, Choueiri, Toni K., additional, and Signoretti, Sabina, additional

Published
2021
Full Text
View/download PDF

29. KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1

Author

Bhatt, Rupal S., primary, Berjis, Abdulla, additional, Konge, Julie C., additional, Mahoney, Kathleen M., additional, Klee, Alyssa N., additional, Freeman, Samuel S., additional, Chen, Chun-Hau, additional, Jegede, Opeyemi A., additional, Catalano, Paul J., additional, Pignon, Jean-Christophe, additional, Sticco-Ivins, Maura, additional, Zhu, Baogong, additional, Hua, Ping, additional, Soden, Jo, additional, Zhu, Jie, additional, McDermott, David F., additional, Arulanandam, Antonio R., additional, Signoretti, Sabina, additional, and Freeman, Gordon J., additional

Published
2021
Full Text
View/download PDF

31. irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial

Author

Pignon, Jean-Christophe, primary, Jegede, Opeyemi, additional, Shukla, Sachet A., additional, Braun, David A., additional, Horak, Christine E., additional, Wind-Rotolo, Megan, additional, Ishii, Yuko, additional, Catalano, Paul J., additional, Grosha, Jonian, additional, Flaifel, Abdallah, additional, Novak, Jesse S., additional, Mahoney, Kathleen M., additional, Freeman, Gordon J., additional, Sharpe, Arlene H., additional, Hodi, F. Stephen, additional, Motzer, Robert J., additional, Choueiri, Toni K., additional, Wu, Catherine J., additional, Atkins, Michael B., additional, McDermott, David F., additional, and Signoretti, Sabina, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results